Navigation Links
SyntheMed Completes $2.8 Million Equity Financing
Date:9/3/2007

ISELIN, N.J., Aug. 14 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), today announced that it has completed the initial closing of a private placement in which it received $2.8 million in gross proceeds. Robert P. Hickey, the Company's President and CEO, stated, "The proceeds of this financing will help fund the US launch of REPEL-CV(R) Adhesion Barrier planned for the fourth quarter of this year."

At the closing, the Company issued and sold 2.8 million shares of Common Stock at $1.00 per share to a consortium of accredited overseas investors. The Company has authorized the sale of an additional 3.2 million shares in the private placement on the same terms. The Company has agreed to file a registration statement with the SEC covering the resale of the privately-placed shares within thirty days following final closing of the placement, which is anticipated to occur on or before August 31, 2007.

The securities offered in the private placement have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products based on its proprietary bioresorbable polymer technology.

Statements in this Press Release that are not statements of historical fact, including statements regarding indications of the timing or ability to achieve regulatory approval and market launch for REPEL-CV or the potential market size for REPEL-CV, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future re
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Worlds largest rainforest drying experiment completes first phase
2. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
3. Sandia completes depleted uranium study
4. LIAI completes worlds most comprehensive analysis on influenza virus data
5. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
6. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
7. Six million Africans face famine because of locusts, drought
8. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
9. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
10. $5.1 billion would save 6 million children
11. Health costs soar as 60 million Americans classed as obese

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- T...oday a report revealing that the last remaining po...gnificantly due to the rising tide of poaching and... will help inform Russian officials of what needs ... world,s biggest cat. , The report ...
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
Breaking Biology News(10 mins):A coating for life 2Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Geneticists coordinate action to fight against traffic in human beings 10675 1Geneticists coordinate action to fight against traffic in human beings 10675 2Geneticists coordinate action to fight against traffic in human beings 10675 3Noted entomologist to receive science excellence award 10672 1Noted entomologist to receive science excellence award 10672 2Noted entomologist to receive science excellence award 10672 3Common Infections May Contribute to Strokes 61075 1Common Infections May Contribute to Strokes 61075 2Common Infections May Contribute to Strokes 61075 3
...ing blocks of life--is exploding as scientists wor...th, disease and the development of organisms. The ...need for researchers to develop a shared vocabular...ing their findings. , An international team of RNA... has now been formed to do just that. , "The cons...
...gy (IBN) has developed a novel method to simultane...cles, which can be used in pharmaceutical synthesi...dbreaking research was recently featured in the le...United States patent has been filed on the inventi...ive Director Prof. Jackie Y. Ying have developed a...
...ed an automated literature search tool for the mul...ol is available as a free plug-in to Cytoscape 2.1...les researchers to form a visual map of complex bi...of molecular pathways and the biological causes of...omatically searches for and extracts information f...
Other Biology News:RNA project to create language for scientists worldwide 2RNA project to create language for scientists worldwide 3Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications 2Agilent Technologies releases automated literature search tool for biology researchers 2Agilent Technologies releases automated literature search tool for biology researchers 3
(Date:11/25/2009)...tochromatodayannouncedtheappointmentofPeterMoldt,P...kSporkastheNovoA/SrepresentativeontheCompany,sBoar...ers. ,, "WeareverypleasedtowelcomePeterMoldttot...andguidanceasCytochromacontinuestomakeprogressinbe...mpany,"statedAlanLewis,PhD,ChairmanofCytochroma,sB...
(Date:11/24/2009).... , Whether it,s CD packaging, containers or...Identification) are increasingly finding their way...l objects or goods and identify them automatically...ead and process the data contained in the label. S...on conditions of up to 100 degrees Celsius. But at...
(Date:11/24/2009)...re/--TwomoreprestigiousuniversitieshavejoinedBioCa...erssiteforlifescienceprofessionals. ,, Northwes...d,joining28othermajorlifesciencetrainingInstitutio...onlyforpost-graduatesinthelifesciences.Whiletherea...oCareerCenteristheonlyonethatserveslifesciencepost...
(Date:11/24/2009)...mployment grew by 29,000 jobs in October, and the...wth during the U.S. recession. However, clinics an...h systems are coming closer to having to actually ...ors. , (Vocus) November 2...g in October despite the shedding of jobs in most ...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...,s Structure-Based Drug Discovery Capabilities, I...Company (NYSE: LLY ) and SGX Pharmaceuticals, Inc...ies have signed a definitive merger agreement,prov...ansaction. SGX, based,in San Diego, California, is... and development in the area of oncology. Under th...
..., July 8 Biotech and pharmaceutical,firms are dev...eamline the,complicated drug discovery process, re...GEN). Most successful approaches rely on a combina...rization techniques, and,advanced data-analysis to...ttp://www.genengnews.com/articles/chitem.aspx?aid=...
...nanomedical applications in diagnostics, imaging, ...EVELAND, July 8 The Nano-Network, Cleveland Clini...rve University today,announced the organizations w...he use of nanoparticles for diagnostics, imaging a...atient care., The 2008 NanoMedicine Summit will t...
Other Biology Technology:Lilly to Acquire SGX Pharmaceuticals 2Lilly to Acquire SGX Pharmaceuticals 3Lilly to Acquire SGX Pharmaceuticals 4Lilly to Acquire SGX Pharmaceuticals 5GEN Reports on Novel Hit-to-Lead Drug Discovery Strategies 2NanoMedicine Summit Returns to Cleveland, September 25-26 2NanoMedicine Summit Returns to Cleveland, September 25-26 3NanoMedicine Summit Returns to Cleveland, September 25-26 4
pRSET-E Echo Expression Vector Kit from Invitrogen
arrayWoRxe from Applied Precision, LLC
TopSpot E non-contact microarrayer from Parallabs
LabCD ADMET System from Tecan
Biology Products: